Search - tctmd.com

Displaying 21 - 32 of 32

Sort: Relevancy | Date

News Industry News

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

June 19, 2015

News Industry News

Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions

June 05, 2015

News Daily News

High-Risk Acute MI Patients Less Likely to Stay on Guideline-Recommended Therapies After Hospital Discharge

Yael L. Maxwell

April 03, 2015

News Industry News

Novartis to showcase heart failure leadership at ESC Congress 2014 with results on new first of its type medicine LCZ696

August 11, 2014

News Daily News

Study of STEMI Care in China Exposes Crucial Treatment Gaps

L.A. McKeown

June 27, 2014

News Daily News

SYMPLICITY HTN-2: Renal Denervation Safe, Effective at 3 Years

Yael L. Maxwell

June 11, 2014

News Daily News

MADIT-CRT: Resynchronization Ups Survival in Patients with Mild Heart Failure and LBBB

Caitlin E. Cox

April 03, 2014

News Daily News

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

L.A. McKeown

March 20, 2014

News Conference News AHA 2013

Similar Long-term Benefits With Mitral Valve Repair, Replacement for Ischemic MR

Yael L. Maxwell

November 19, 2013

News Conference News ESC 2013

AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction

Caitlin E. Cox

September 04, 2013

News Daily News

Intracoronary ACE Inhibitor Reduces Microvascular Damage in Elective PCI

Yael L. Maxwell

January 06, 2013

News Daily News

Coronary Reactivity Testing Relatively Safe in High-Risk Women Without CAD

June 25, 2012

Advertisement

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions

High-Risk Acute MI Patients Less Likely to Stay on Guideline-Recommended Therapies After Hospital Discharge

Novartis to showcase heart failure leadership at ESC Congress 2014 with results on new first of its type medicine LCZ696

Study of STEMI Care in China Exposes Crucial Treatment Gaps

SYMPLICITY HTN-2: Renal Denervation Safe, Effective at 3 Years

MADIT-CRT: Resynchronization Ups Survival in Patients with Mild Heart Failure and LBBB

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

Similar Long-term Benefits With Mitral Valve Repair, Replacement for Ischemic MR

AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction

Intracoronary ACE Inhibitor Reduces Microvascular Damage in Elective PCI

Coronary Reactivity Testing Relatively Safe in High-Risk Women Without CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content